Tokyo District Court renders judgment on the patent infringement lawsuit concerning Rituxan intravenous infusion
Wednesday, May 29, 2019 DrugName : rituximab Chugai Pharmaceutical Co., Ltd. announced that the Tokyo District Court has rendered judgment dismissing
Read More